Angion Biomedica Corp   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Uniondale NY United States (1998)

Organization Overview

First Clinical Trial
2010
NCT01286727
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Angion Biomedica | Angion Biomedica Corp